Genetic Diagnosis and Molecular Monitoring in the Management of Acute Promyelocytic Leukemia

This publication has 95 references indexed in Scilit:

• Absence of detectable PML-RARα fusion transcripts in long-term remission patients after BMT for acute promyelocytic leukemia
  Bone Marrow Transplantation, 1997
• Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukaemia
  British Journal of Haematology, 1997
• Quantification of PML‐RARα transcripts in acute promyelocytic leukaemia: explanation for the lack of sensitivity of RT‐PCR for the detection of minimal residual disease and induction of the leukaemia‐specific mRNA by alpha interferon
  British Journal of Haematology, 1996
• Molecular analysis of PML‐RARa fusion mRNA detected by reverse transcription‐polymerase chain reaction assay in long‐term disease‐free acute promyelocytic leukaemia patients
  British Journal of Haematology, 1995
• Early detection of minimal residual disease by reverse transcriptase polymerase chain reaction predicts relapse in acute promyelocytic leukemia
  Annals of Hematology, 1995
• Acute promyelocytic leukemia: From clinic to molecular biology
  The International Journal of Cell Cloning, 1995
• Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells
  Cell, 1994
• Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemia
  The Lancet, 1992
• The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR
  Cell, 1991
• Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML
  Cell, 1991